跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUDAFED NASAL DECONGESTANT oxymetazoline hydrochloride 0.5mg/mL spray solution bottle - TGA Drug Approval Details
Approvals
/
TGA
/
SUDAFED NASAL DECONGESTANT oxymetazoline hydrochloride 0.5mg/mL spray solution bottle
Approved
STANDARD
SUDAFED NASAL DECONGESTANT oxymetazoline hydrochloride 0.5mg/mL spray solution bottle
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
29abaf0c8a1d190a
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
29abaf0c8a1d190a
Product Name
SUDAFED NASAL DECONGESTANT oxymetazoline hydrochloride 0.5mg/mL spray solution bottle
Artg Id
148398
Artg Name
SUDAFED NASAL DECONGESTANT oxymetazoline hydrochloride 0.5mg/mL spray solution bottle
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
2007-12-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
29abaf0c8a1d190a
Type
Standard
Back to TGA Approvals
